does novo nordisk have a patent on semaglutide

does novo nordisk have a patent on semaglutide New Delhi, March 19, 2026 – Friday, the key on semaglutide—the active molecule in Nordisk's blockbuster drugs Ozempic and Wegovy—expired in India, marking pivotal shift in the country's Novo Nordisk scores court win

Name: does novo nordisk have a patent on semaglutide New Delhi, March 19, 2026 – Friday, the key on semaglutide—the active molecule in Nordisk's blockbuster drugs Ozempic and Wegovy—expired in India, marking pivotal shift in the country's Novo Nordisk scores court win
Brand: www.rasophiles.fr
SKU: 34836448949
Price: 28.60 USD
Availability: InStock
Rating: 4.6795 (27 reviews)

SKU: 34836448949

4.7

EUR28.60 EUR49.60

Pay in 4 interest-free payments of $7.15 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 20 - Aug 25

Description

Any retatrutide preparation that has been frozen or is suspected of having been frozen should not be used

Genetic Predisposition Some individuals naturally develop thinning with age

"The US market alone could scale to $10bn within a few years as obesity rates drive demand." That would be a sizeable addition to India's pharmaceutical trade: the country's generic drug exports currently total $30.46bn, with the US already its largest market